Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
USE OF ALBUMIN AND OTHER PLASMA SUBSTITUT ES FROM 1989 TO 1993 IN A FRENCH UNIVERSITY HOSPITAL
Autore:
AUDIBERT G; CHARPENTIER C; SAVOYE E; LAXENAIRE MC;
Indirizzi:
HOP CENT,DEPT ANESTHESIE REANIMAT,29 AVE MARECHAL DE LATTRE DE TASSIGNY F-54000 NANCY FRANCE
Titolo Testata:
Annales francaises d'anesthesie et de reanimation
fascicolo: 6, volume: 14, anno: 1995,
pagine: 517 - 522
SICI:
0750-7658(1995)14:6<517:UOAAOP>2.0.ZU;2-1
Fonte:
ISI
Lingua:
FRE
Soggetto:
CRITICALLY ILL; SUPPLEMENTATION; PARACENTESIS; ASCITES;
Keywords:
ALBUMIN; GELATIN; DEXTRAN; STARCH; PLASMA SUBSTITUTES; COLLOIDS; CONSENSUS;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
21
Recensione:
Indirizzi per estratti:
Citazione:
G. Audibert et al., "USE OF ALBUMIN AND OTHER PLASMA SUBSTITUT ES FROM 1989 TO 1993 IN A FRENCH UNIVERSITY HOSPITAL", Annales francaises d'anesthesie et de reanimation, 14(6), 1995, pp. 517-522

Abstract

Objectives: To evaluate the nse of plasma substitutes (albumin, gelatins, dextrans, starches) from 1989 to 1993 in a 3000-bed University hospital and to assess the impact of the 1989 consensus conference of the French speaking Society of Intensive Care Medicine on the choice of plasma substitutes for treatment of hypovolaemia. Study design: Retrospective study of a case series. Methods: Data on the use of albumin and artificial plasma substitutes were obtained from Blood Bank and Pharmacy. Results: Between 1989 and 1993, the total amount of administeredplasma substitutes decreased by 20%, allowing a saving of 1.7 millionFF. There was a 60% decrease in the use of gelatins and dextrans. Thestarches, introduced in 1991, became in 1993 the most used plasma substitute, with 37% of the total. The use of albumin showed only a 32% decrease and was still in 1993 the main source of expenditure for plasma substitutes, with 3.8 million FF and 80% of the total cost. The number of plasmapheresis increased by 15%, whereas the use of albumin for plasmapheresis, almost constant in absolute value, increased from 31% in 1989 to 45% in 1993 of the total expenses. There were large differences between the services regarding the use of albumin. Intensive careand surgical units represented 70% of the total (plasmapheresis excluded). In this group, the overall fall of use was 22%, some units obtaining a 93% decrease whereas other did not change in spite of constant admission numbers. Medical units decreased their albumin use by 53%. Conclusion: The decrease in the albumin use between 1989 and 1993 was not significant. The impact of the consensus conference, if any, was weak. A careful evaluation of the prescriptions would be necessary to improve the compliance of clinical practice with recommendations by the consensus conference.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/09/20 alle ore 12:04:37